Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zanubrutinib in Relapsed or Refractory Warm Autoimmune Hemolytic Anemia: a Prospective Cohort Study

NCT05922839 is registered in ClinicalTrials.gov with Chen Miao as lead sponsor.

NCT NCT05922839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05922839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zanubrutinib in Relapsed or Refractory Warm Autoimmune Hemolytic Anemia: a Prospective Cohort Study
Lead sponsor
Chen Miao
Phase
Phase 2
Overall status
Unknown status
Start date
November 11, 2023
Completion date
December 31, 2025
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

warm autoimmune hemolytic anemia